Altimmune, Inc. (ALT) Tops Q4 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Roblox announces standalone apps, browser play, and creator wallet
• 37 Capital raises $300,000 in partial private placement closing